Dietary Supplements for Reduction of Intestinal Permeability Levels
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversidad Complutense de Madrid
About this trial
A randomised and controlled trial, in which the effect of a dietary supplement is evaluated for reduction of intestinal permeability levels of subjects with high levels of zonulin in feces
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Subjects between 18 and 65 years of age with elevated levels of zonulin in stool (greater than 80 ng/ml).
Disqualifiers
Taking any type of antibiotic in the last month
Taking prebiotics or probiotics products in the last month.
Taking laxatives in the last month.
Undergoing any medicinal treatment
Trial design
Design model
Parallel
Treatments tested in this trial
Dietary supplement Group
Dietary supplementSubjects belonging to the experimental group will be provided with the PermeaIntest supplement, which they will take for 60 days, 1 sachet in the morning and 1 sachet in the evening in half a glass of water. Subjects will have a stool sample collected before and after ingestion of the dietary supplement.
Treatment groups
85 Participants
are divided into 2 treatment groupsGroup A: Dietary supplement GroupExperimental treatment 1 intervention
Group B: Control groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Zonulin levels in feces
Zonulin levels in feces, assessed in ng/ml
Time frame
60 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: